Targeting NADPH oxidases improves response to FLT3 inhibitors for the treatment of AML

Zac Germon; Jonathan Sillar; Abdul Mannan; Ryan Duchatel; Heather Murray; Alicia Douglas; Honggang Huang; Frank Alvaro; Janis Chamberlain; Andrew Wei; Geoffry De Luliis; Anoop Enjeti; Martin Larsen; Nicole Verrills; Matthew Dun

Targeting NADPH oxidases improves response to FLT3 inhibitors for the treatment of AML

Zac Germon, Jonathan Sillar, Abdul Mannan, Ryan Duchatel, Heather Murray, Alicia Douglas, Honggang Huang, Frank Alvaro, Janis Chamberlain, Andrew Wei, Geoffry De Luliis, Anoop Enjeti, Martin Larsen, Nicole Verrills, Matthew Dun

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Journal	Asia Pacific Journal of Clinical Oncology
Volume	17
Issue number	S5
Pages (from-to)	59
Number of pages	1
ISSN	1743-7555
Publication status	Published - Sept 2021
Event	Sydney Cancer Conference 2021: Bridging Research and Practice - Duration: 9. Sept 2021 → 10. Sept 2021

Conference

Conference	Sydney Cancer Conference 2021
Period	09/09/2021 → 10/09/2021

Documents & Links

https://doi.org/10.1111/ajco.13652

SDU Link

Check access to the material in SDU Library's search engine

Cite this

Germon, Z., Sillar, J., Mannan, A., Duchatel, R., Murray, H., Douglas, A., Huang, H., Alvaro, F., Chamberlain, J., Wei, A., De Luliis, G., Enjeti, A., Larsen, M., Verrills, N., & Dun, M. (2021). Targeting NADPH oxidases improves response to FLT3 inhibitors for the treatment of AML. Asia Pacific Journal of Clinical Oncology, 17(S5), 59. https://doi.org/10.1111/ajco.13652

@article{7ee77857a3ef4b7a80a22921101115ae,

title = "Targeting NADPH oxidases improves response to FLT3 inhibitors for the treatment of AML",

author = "Zac Germon and Jonathan Sillar and Abdul Mannan and Ryan Duchatel and Heather Murray and Alicia Douglas and Honggang Huang and Frank Alvaro and Janis Chamberlain and Andrew Wei and {De Luliis}, Geoffry and Anoop Enjeti and Martin Larsen and Nicole Verrills and Matthew Dun",

year = "2021",

month = sep,

language = "English",

volume = "17",

pages = "59",

journal = "Asia Pacific Journal of Clinical Oncology",

issn = "1743-7555",

publisher = "Wiley",

number = "S5",

note = "Sydney Cancer Conference 2021 ; Conference date: 09-09-2021 Through 10-09-2021",

}

Germon, Z, Sillar, J, Mannan, A, Duchatel, R, Murray, H, Douglas, A, Huang, H, Alvaro, F, Chamberlain, J, Wei, A, De Luliis, G, Enjeti, A, Larsen, M, Verrills, N & Dun, M 2021, 'Targeting NADPH oxidases improves response to FLT3 inhibitors for the treatment of AML', Asia Pacific Journal of Clinical Oncology, vol. 17, no. S5, pp. 59. <https://doi.org/10.1111/ajco.13652>

TY - ABST

T1 - Targeting NADPH oxidases improves response to FLT3 inhibitors for the treatment of AML

AU - Germon, Zac

AU - Sillar, Jonathan

AU - Mannan, Abdul

AU - Duchatel, Ryan

AU - Murray, Heather

AU - Douglas, Alicia

AU - Huang, Honggang

AU - Alvaro, Frank

AU - Chamberlain, Janis

AU - Wei, Andrew

AU - De Luliis, Geoffry

AU - Enjeti, Anoop

AU - Larsen, Martin

AU - Verrills, Nicole

AU - Dun, Matthew

PY - 2021/9

Y1 - 2021/9

M3 - Conference abstract in journal

C2 - 34486817

SN - 1743-7555

VL - 17

SP - 59

JO - Asia Pacific Journal of Clinical Oncology

JF - Asia Pacific Journal of Clinical Oncology

IS - S5

T2 - Sydney Cancer Conference 2021

Y2 - 9 September 2021 through 10 September 2021

ER -